Medigus Subsidiary Metagramm To Develop Bubbl, AI-Powered Writing And Grammar Tool
$MDGS
Medical/Dental Instruments
Health Care
Medigus Subsidiary Metagramm To Develop Bubbl, AI-Powered Writing And Grammar Tool
Save time and jump to the most important pieces.
SC 13G/A - Medigus Ltd. (0001618500) (Filed by)
SC 13G - Medigus Ltd. (0001618500) (Filed by)
SC 13D - Medigus Ltd. (0001618500) (Filed by)
TEL AVIV, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that ParaZero Technologies Ltd. (NASDAQ:PRZO) ( "ParaZero"), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircraft (18.68% owned by Xylo), initiated a partnership with a leading Tier 1 defense OEM company to adapt and integrate its advanced drone safety system for operational military and medical mission use. ParaZero received an initial order as part of a wider collaboration that aims to enhance the efficiency and safety of
TEL AVIV, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd ("Revoltz"), which is 19.9% held by Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation quoted on the OTC Market (67% owned by Xylo), has developed a new, three-wheel, electric cargo bike tailored for the European and UK markets. Building on the success of Revoltz's PORTO micro-EV, this new bike is designed to offer enhanced stability, increased payload capacity, and high-caliber safety features, making it fit for urban transportation and comme
Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" and the "Company"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and charging solutions, announced today that it plans a ratio change which will result in a reverse split of the Company's American Depositary Receipt, or ADR, program on the basis of one (1) new ADS for every 2.666666 old ADSs held. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from fifteen (15) ordinary shares to forty (40) ordinary shares. The effective date anticipated f
Metagramm Software Ltd. has developed an advanced grammar engine, which serves as the core of its online writing solution and a fully integrated writing solution for Windows desktop Tel Aviv, Israel, April 13, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today it has acquired 19.9% of Metagramm Software Ltd. ("Metagramm"), an innovative AI, machine learning (ML) communication and grammar assistant software. In return, Medigus paid Metagramm $250,000 in Medigus' common shares. Metagramm is one of the first comp
TEL AVIV, Israel, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) ("Medigus"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today reported financial results for the six months ended June 30, 2022. Key Highlights Generated record revenues of $34.95 million in the first half of 2022, compared to $2.39 million revenues in the first half of 2021Gross profit reached a record $6.19 million in the first half of 2022, up from a gross profit of $0.6 million in the first half of 2021Cash and cash equivalents as of June 30, 2022 were $22.1 millionShareholders' equity improved to $53.19 million
Tel Aviv, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution up to of $1.6 million. The Company's motion, if approved as requested, would permit the Company to distribute a dividend to the holders of the Company's American Depositary Shares in proportion to their respective holdings. A separate announcement would be made if the Company's board of directors were to declare such a dividend.
Tel Aviv, Israel, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) ("Medigus"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and charging solutions, announced today that ScoutCam Inc. (OTCQB:SCTC) ("ScoutCam", owned 27.02% by Medigus), a leading provider of visualization and AI based solutions to the Condition Based Monitoring (CBM) and the Predictive Maintenance (PdM) markets, announced the appointment of Yehu Ofer as chief executive officer, effective immediately. Mr. Ofer, a former Israeli Air Force (IAF) pilot and commander, as well as a leading professional in the aviation and aerospace industries,
OMER, Israel, March 08, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that ScoutCam Inc (OTCQB:SCTC), Medigus’ subsidiary and a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, appointed Mr. Yovav Sameah as ScoutCam’s new Chief Executive Officer. Mr. Sameah will replace Dr. Yaron Silberman, who will step down to pursue new opportunities. Mr. Sameah is a senior level executive with extensive hands-on experience in management, business leadership and strategy. He most recently served as CEO of Frontline PCB So
Gainers Jaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $1.9. The company's market cap stands at $128.7 million. Corvus Pharma (NASDAQ:CRVS) shares increased by 7.36% to $1.75. The market value of their outstanding shares is at $85.8 million. ImmuCell (NASDAQ:ICCC) shares increased by 7.27% to $5.6. The market value of their outstanding shares is at $43.4 million. Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 6.46% to $0.16. The company's market cap stands at $6.9 million. Xilio Therapeutics (NASDAQ:XLO) shares increased by 5.34% to
The rebranding includes a new name and an update to the Company's corporate logo, as well as a new website.
Following completion of initial production, Revoltz sets up for delivery in accordance with its distribution agreement (the "Agreement"), aiming to sell 150 vehicles in the first year of the AgreementTel Aviv, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and charging solutions, announced today that Revoltz Ltd, its EV joint venture, 19.9% owned by its subsidiary Fuel Doctor Holdings, Inc. (67.15%), completed its first production batch of 50 units of its micro-mobility electric vehicle, ‘PORTO'.The completion of production is a significant step in
6-K - XYLO TECHNOLOGIES LTD (0001618500) (Filer)
20-F - XYLO TECHNOLOGIES LTD (0001618500) (Filer)
6-K - XYLO TECHNOLOGIES LTD (0001618500) (Filer)